Formulation expertise
15 years and 100+ years of collective R&D experience refining the format.
From ideation to market, ODFinity™ is Shilpa Medicare’s proprietary, fully integrated oral disintegrating film platform — a one-stop solution for ODF manufacturing.
ODFinity™ films dissolve in seconds — clean-label, flavourful and effortless to take. For our partners, that’s not just a better dose. It’s a more competitive product.




A conventional tablet travels through the digestive tract and liver, taking around 40 minutes to begin absorbing. An ODFinity™ film disintegrates on the tongue in seconds — designed for rapid onset and an effortless experience, no water required.
Most partners carry integration risk across formulation, manufacturing and regulatory. We remove it — one partner, one accountable platform, one path to market.
15 years and 100+ years of collective R&D experience refining the format.
Fully automated German & Italian lines; first-in-India combi-line for ODF.
21 CFR-compliant QC — every test run in-house.
A deep, defensible IP foundation.
Products and approvals across 50+ countries.
Formats engineered for diverse markets and brands.
Among the first to commercialise Paracetamol and Ondansetron as oral disintegrating films.
From Rivaroxaban — the first ODF approved across the EU — to CNS, men’s health, pain relief and clean-label nutraceuticals, we’ve formulated films across 10+ therapeutic areas. Rx, OTC and nutraceutical.
First ODF approved across all 30 EU/EEA countries.
Neurology & vestibular care.
Pain, fever & anti-nausea.
Clean-label daily wellness.
ODFinity™ is built on the foundation of Shilpa Medicare — a global pharmaceutical company spanning APIs, formulations, biologics and CDMO services. Nearly four decades of scientific depth stand behind every film we make.
About Shilpa & ODFinity →White-label, private-label, CDMO and fully custom formulation — wherever you are in the journey, we’ll meet you there.
Partner with us


